Article Details

Minerva Neurosciences Inc (NASDAQ: NERV) Submits New Drug Application ... - BioPharmaJournal

Retrieved on: 2022-09-02 16:58:30

Tags for this article:

Click the tags to see associated articles and topics

Minerva Neurosciences Inc (NASDAQ: NERV) Submits New Drug Application ... - BioPharmaJournal. View article details on hiswai:

Excerpt

Minerva Neurosciences Inc (NASDAQ: NERV) has announced the submission of a New Drug Application to the US FDA for roluperidone in treating ...

Article found on: biopharmajournal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up